dQ&A Study:
Comparing Health Outcomes for People with T1D in the USA and EU

What's the Story?

People with Type 1 diabetes (PWT1) in Europe (EU) and the United States (USA) generally have similar access to diabetes technologies. So how do their health outcomes compare?

dQ&A’s work shows that even with similar treatment plans, differing regional factors influencing diabetes management — such as obesity levels and the cost and accessibility of healthcare — potentially affect patient wellness.

Real members of the dQ&A diabetes community.
Photos used by permission.

dQ&A Study Methodology

Our latest study examines health outcomes of n=4,343 adults with Type 1 diabetes in 7 countries.

Respondents reported:
  • Diabetes-related complications
  • Their means of insulin administration: Multiple Daily Injections (MDI), traditional (open-loop) insulin pump (Pump non-AID), or an automated (closed loop) insulin delivery system (AID system)
  • Their mental well-being using the World Health Organization – Five Well-Being Index (WHO-5)

Study Findings

Obesity and A1c
In the USA, a significantly greater percentage of PWT1 are classified as obese compared to those in the EU (28% vs. 25%, p<0.05). This regional difference in obesity is enough to be significant at a public health level.

Nevertheless, patients in the USA have better glycemic control than those in the EU – regardless of their treatment method.
Statistical significance: * p<0.05, ** p<0.01
Diabetes-Related Health Complications
In the USA, PWT1 experience a greater average number of diabetes-related health issues than those in the EU, irrespective of their therapy regime.
Statistical significance: * p<0.05, ** p<0.01
Conclusions
Our study showed that PWT1 in the EU have worse glycemic control (as well as worse overall mental well-being).

Conversely, PWT1 in the USA have stronger glycemic control, but higher rates of obesity and health complications – emphasizing the prevalence of poor weight-related outcomes in the USA.

Download the study, including additional data showing the prevalence of poor mental-well being among PWT1.

Karen

Creative, Up-beat Moderator/Interviewer

"Insights I draw from our amazing panelists influence our client's smart decisions and directly improve life for very people I get to interview! How great is that?!”

Trevor

Mixed-Methods Research Expert. Multiple Published Papers.

"As someone with T1D, I'm grateful our work directly impacts devices and therapies”

Christianne

Data Services Architect. Career Research Guru.

“I have been working with dQ&A for over ten years, 100% focused on diabetes. I so love contributing to those mission-critical decisions.”

Phin

VP, Research Services. Structures big data to drive analysis and insight.

“It's a real privilege to work with data that can make such a significant difference”

Kim

10 Years on the Client Side. Delivers Actionable Insights

“At dQ&A I’m surrounded by seasoned researchers and compassionate individuals, united in our mission to make life better for people living with diabetes”

Phyllisa

Patient Advocate. Manages Content for People With Diabetes

“For the first time in my career, I don't deal with diabetes stigma in the workplace.”

You have Questions. We have Answers.

Contact us for more information on our recent study comparing health outcomes among people with Type 1 Diabetes in the EU and the USA.

Do You Have Questions
About Diabetes Research?

We Have Answers.

This research excerpt is just the tip of the iceberg. dQ&A has decades of experience across the United States, Canada, and Europe. If you drive critical diabetes research decisions in your organization, dQ&A is the diabetes insight partner that can get the answers you need.